{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T23:58:21Z","timestamp":1782431901411,"version":"3.54.5"},"reference-count":51,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1016\/j.metabol.2007.09.008","type":"journal-article","created":{"date-parts":[[2008,1,11]],"date-time":"2008-01-11T11:03:15Z","timestamp":1200049395000},"page":"246-254","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["Differential effect of fenofibrate and atorvastatin on in vivo kinetics of apolipoproteins B-100 and B-48 in subjects with type 2 diabetes mellitus with marked hypertriglyceridemia"],"prefix":"10.1016","volume":"57","author":[{"given":"Jean-Charles","family":"Hogue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beno\u00eet","family":"Lamarche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Deshaies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9 J.","family":"Tremblay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Bergeron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claude","family":"Gagn\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Couture","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.metabol.2007.09.008_bib1","first-page":"S19","article-title":"Lipoprotein abnormalities and their consequences for patients with type 2 diabetes","volume":"5","author":"Krentz","year":"2003","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.metabol.2007.09.008_bib2","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1161\/01.CIR.0000035280.64322.31","article-title":"New perspectives on atherogenesis: role of abnormal triglyceride-rich lipoprotein metabolism","volume":"106","author":"Ginsberg","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2007.09.008_bib3","doi-asserted-by":"crossref","first-page":"3542","DOI":"10.1161\/01.ATV.17.12.3542","article-title":"Lipoprotein heterogeneity and apolipoprotein B metabolism","volume":"17","author":"Packard","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.metabol.2007.09.008_bib4","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1161\/01.CIR.98.19.2088","article-title":"Mechanism of action of fibrates on lipid and lipoprotein metabolism","volume":"98","author":"Staels","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2007.09.008_bib5","doi-asserted-by":"crossref","first-page":"16B","DOI":"10.1016\/0002-9149(90)90436-5","article-title":"Comparison of the effects of lovastatin and gemfibrozil on lipids and glucose control in non\u2013insulin-dependent diabetes mellitus","volume":"66","author":"Goldberg","year":"1990","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.metabol.2007.09.008_bib6","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/0149-2918(95)80018-2","article-title":"Effects of simvastatin versus gemfibrozil on lipids and glucose control in patients with non\u2013insulin-dependent diabetes mellitus. NIDDM Study Group","volume":"17","author":"Sweany","year":"1995","journal-title":"Clin Ther"},{"key":"10.1016\/j.metabol.2007.09.008_bib7","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S0002-9149(97)00965-X","article-title":"Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study)","volume":"81","author":"Jones","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.metabol.2007.09.008_bib8","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/00041433-199706000-00003","article-title":"3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors and hepatic apolipoprotein B secretion","volume":"8","author":"Huff","year":"1997","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.metabol.2007.09.008_bib9","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0002-9149(00)01270-4","article-title":"Effects of atorvastatin versus fenofibrate on lipoprotein profiles, low-density lipoprotein subfraction distribution, and hemorheologic parameters in type 2 diabetes mellitus with mixed hyperlipoproteinemia","volume":"87","author":"Frost","year":"2001","journal-title":"Am J Cardiol."},{"key":"10.1016\/j.metabol.2007.09.008_bib10","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0021-9150(99)00125-2","article-title":"Atorvastatin increases low-density lipoprotein size and enhances high-density lipoprotein cholesterol concentration in male, but not in female patients with familial hypercholesterolemia","volume":"146","author":"Hoogerbrugge","year":"1999","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.metabol.2007.09.008_bib11","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0021-9150(02)00385-4","article-title":"Effects of atorvastatin on electrophoretic characteristics of LDL particles among subjects with heterozygous familial hypercholesterolemia","volume":"167","author":"Larivi\u00e8re","year":"2003","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.metabol.2007.09.008_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-2275(20)33334-4","article-title":"Remnant lipoprotein metabolism: key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E","volume":"40","author":"Mahley","year":"1999","journal-title":"J Lipid Res"},{"key":"10.1016\/j.metabol.2007.09.008_bib13","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0021-9150(97)00291-8","article-title":"Remnants of chylomicron and very low density lipoprotein impair endothelium-dependent vasorelaxation","volume":"137","author":"Doi","year":"1998","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.metabol.2007.09.008_bib14","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/00041433-200210000-00001","article-title":"Arterial retention of apolipoprotein B(48)- and B(100)-containing lipoproteins in atherogenesis","volume":"13","author":"Proctor","year":"2002","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.metabol.2007.09.008_bib15","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s11883-005-0037-x","article-title":"Remnant lipoproteins and atherosclerosis","volume":"7","author":"Twickler","year":"2005","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.metabol.2007.09.008_bib16","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1161\/01.CIR.91.9.2488","article-title":"Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics","volume":"91","author":"Berliner","year":"1995","journal-title":"Circulation"},{"issue":"Suppl 1","key":"10.1016\/j.metabol.2007.09.008_bib17","first-page":"S5","article-title":"Report of the expert committee on the diagnosis and classification of diabetes mellitus","volume":"27","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2007.09.008_bib18","series-title":"A biometric study of basal metabolism in man","author":"Harris","year":"1919"},{"key":"10.1016\/j.metabol.2007.09.008_bib19","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1194\/jlr.M200479-JLR200","article-title":"Characterization of a novel mutation causing hepatic lipase deficiency among French-Canadians","volume":"44","author":"Ruel","year":"2003","journal-title":"J Lipid Res"},{"key":"10.1016\/j.metabol.2007.09.008_bib20","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0022-2275(20)40071-9","article-title":"Quantification of apolipoproteins B-100, B-48, and E in human triglyceride-rich lipoproteins","volume":"36","author":"Kotite","year":"1995","journal-title":"J Lipid Res"},{"key":"10.1016\/j.metabol.2007.09.008_bib21","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1016\/S0022-2275(20)38247-X","article-title":"Quantitation of apoB-48 and apoB-100 by gel scanning or radio-iodination","volume":"30","author":"Zilversmit","year":"1989","journal-title":"J Lipid Res"},{"key":"10.1016\/j.metabol.2007.09.008_bib22","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1161\/01.ATV.19.12.2966","article-title":"Human apolipoprotein (Apo) B-48 and Apo B-100 kinetics with stable isotopes","volume":"19","author":"Welty","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.metabol.2007.09.008_bib23","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/S0022-2275(20)30177-2","article-title":"Oxazolinone derivative of leucine for GC-MS: a sensitive and robust method for stable isotope kinetic studies of lipoproteins","volume":"43","author":"Dwyer","year":"2002","journal-title":"J Lipid Res"},{"key":"10.1016\/j.metabol.2007.09.008_bib24","first-page":"E551","article-title":"Models to interpret kinetic data in stable isotope tracer studies","volume":"253","author":"Cobelli","year":"1987","journal-title":"Am J Physiol"},{"key":"10.1016\/j.metabol.2007.09.008_bib25","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1161\/01.ATV.0000216750.09611.ec","article-title":"Effect of ezetimibe on the in vivo kinetics of apoB-48 and apoB-100 in men with primary hypercholesterolemia","volume":"26","author":"Tremblay","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.metabol.2007.09.008_bib26","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1172\/JCI114507","article-title":"Measurement of very low density and low density lipoprotein apolipoprotein (Apo) B-100 and high density lipoprotein Apo A-I production in human subjects using deuterated leucine. Effect of fasting and feeding","volume":"85","author":"Cohn","year":"1990","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2007.09.008_bib27","doi-asserted-by":"crossref","first-page":"989","DOI":"10.2337\/diacare.25.6.989","article-title":"Elevated remnant-like particle cholesterol and triglyceride levels in diabetic men and women in the Framingham Offspring Study","volume":"25","author":"Schaefer","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2007.09.008_bib28","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/BF02048544","article-title":"Elevated triglyceride-rich lipoproteins in diabetes. A study of apolipoprotein B-48","volume":"33","author":"Curtin","year":"1996","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.metabol.2007.09.008_bib29","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1210\/edrv.23.2.0461","article-title":"Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes","volume":"23","author":"Lewis","year":"2002","journal-title":"Endocr Rev"},{"key":"10.1016\/j.metabol.2007.09.008_bib30","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/BF00266035","article-title":"Retarded chylomicron apolipoprotein-B catabolism in type 2 (non\u2013insulin-dependent) diabetic subjects with lipaemia","volume":"26","author":"Haffner","year":"1984","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2007.09.008_bib31","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/0005-2760(92)90298-A","article-title":"Hypertriglyceridemia is exacerbated by slow lipolysis of triacylglycerol-rich lipoproteins in fed but not fasted streptozotocin diabetic rats","volume":"1128","author":"Mamo","year":"1992","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.metabol.2007.09.008_bib32","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1161\/01.ATV.0000222015.76038.14","article-title":"Hyperinsulinemia is associated with increased production rate of intestinal apolipoprotein B-48\u2013containing lipoproteins in humans","volume":"26","author":"Duez","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.metabol.2007.09.008_bib33","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1194\/jlr.M600548-JLR200","article-title":"Evidence of increased secretion of apolipoprotein B-48\u2013containing lipoproteins in subjects with type 2 diabetes","volume":"48","author":"Hogue","year":"2007","journal-title":"J Lipid Res"},{"key":"10.1016\/j.metabol.2007.09.008_bib34","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1073\/pnas.80.13.4124","article-title":"Mevinolin and colestipol stimulate receptor-mediated clearance of low density lipoprotein from plasma in familial hypercholesterolemia heterozygotes","volume":"80","author":"Bilheimer","year":"1983","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.metabol.2007.09.008_bib35","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1210\/jcem.87.5.8455","article-title":"Mechanism of action of a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor on apolipoprotein B-100 kinetics in visceral obesity","volume":"87","author":"Chan","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2007.09.008_bib36","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1194\/jlr.M300309-JLR200","article-title":"Effects of atorvastatin versus fenofibrate on apoB-100 and apoA-I kinetics in mixed hyperlipidemia","volume":"45","author":"Bilz","year":"2004","journal-title":"J Lipid Res"},{"key":"10.1016\/j.metabol.2007.09.008_bib37","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1194\/jlr.M500335-JLR200","article-title":"Treatment with high-dose simvastatin reduces secretion of apolipoprotein B\u2013lipoproteins in patients with diabetic dyslipidemia","volume":"46","author":"Myerson","year":"2005","journal-title":"J Lipid Res"},{"key":"10.1016\/j.metabol.2007.09.008_bib38","doi-asserted-by":"crossref","first-page":"803","DOI":"10.2337\/diabetes.52.3.803","article-title":"Differential regulation of lipoprotein kinetics by atorvastatin and fenofibrate in subjects with the metabolic syndrome","volume":"52","author":"Watts","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2007.09.008_bib39","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0021-9150(02)00052-7","article-title":"Influence of atorvastatin and simvastatin on apolipoprotein B metabolism in moderate combined hyperlipidemic subjects with low VLDL and LDL fractional clearance rates","volume":"164","author":"Forster","year":"2002","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.metabol.2007.09.008_bib40","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1124\/jpet.103.048991","article-title":"Effect of atorvastatin on apolipoprotein B100 containing lipoprotein metabolism in type-2 diabetes","volume":"306","author":"Ouguerram","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.metabol.2007.09.008_bib41","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S0014-5793(99)00632-8","article-title":"3-Hydroxy-3-methylglutaryl CoA reductase inhibitors reduce serum triglyceride levels through modulation of apolipoprotein C-III and lipoprotein lipase","volume":"452","author":"Schoonjans","year":"1999","journal-title":"FEBS Lett"},{"key":"10.1016\/j.metabol.2007.09.008_bib42","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1172\/JCI10852","article-title":"Statin-induced inhibition of the Rho-signaling pathway activates PPARalpha and induces HDL apoA-I","volume":"107","author":"Martin","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2007.09.008_bib43","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1161\/01.ATV.17.1.72","article-title":"A familial combined hyperlipidemic kindred with impaired apolipoprotein B catabolism. Kinetics of apolipoprotein B during placebo and pravastatin therapy","volume":"17","author":"Aguilar-Salinas","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.metabol.2007.09.008_bib44","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1161\/01.ATV.17.10.1910","article-title":"Lovastatin decreases de novo cholesterol synthesis and LDL apo B-100 production rates in combined-hyperlipidemic males","volume":"17","author":"Cuchel","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"10.1016\/j.metabol.2007.09.008_bib45","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/01.mol.0000199815.46720.ca","article-title":"Recent studies of lipoprotein kinetics in the metabolic syndrome and related disorders","volume":"17","author":"Chan","year":"2006","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.metabol.2007.09.008_bib46","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/sj.ijo.0802287","article-title":"Effect of a statin on hepatic apolipoprotein B-100 secretion and plasma campesterol levels in the metabolic syndrome","volume":"27","author":"Watts","year":"2003","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/j.metabol.2007.09.008_bib47","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1007\/s00125-006-0177-8","article-title":"Messenger RNA levels of genes involved in dysregulation of postprandial lipoproteins in type 2 diabetes: the role of Niemann-Pick C1-like 1, ATP-binding cassette, transporters G5 and G8, and of microsomal triglyceride transfer protein","volume":"49","author":"Lally","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2007.09.008_bib48","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1194\/jlr.M300011-JLR200","article-title":"Effect of atorvastatin on postprandial lipoprotein metabolism in hypertriglyceridemic patients","volume":"44","author":"Parhofer","year":"2003","journal-title":"J Lipid Res"},{"key":"10.1016\/j.metabol.2007.09.008_bib49","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S0021-9150(01)00534-2","article-title":"Chylomicron remnant metabolism in familial hypercholesterolaemia studied with a stable isotope breath test","volume":"157","author":"Watts","year":"2001","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.metabol.2007.09.008_bib50","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0002-9343(87)90866-7","article-title":"Fibric acids: effects on lipids and lipoprotein metabolism","volume":"83","author":"Grundy","year":"1987","journal-title":"Am J Med"},{"key":"10.1016\/j.metabol.2007.09.008_bib51","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1172\/JCI111643","article-title":"Apolipoprotein A and B (Sf 100-400) metabolism during bezafibrate therapy in hypertriglyceridemic subjects","volume":"74","author":"Shepherd","year":"1984","journal-title":"J Clin Invest"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049507003289?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049507003289?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T03:28:28Z","timestamp":1758425308000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049507003289"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2]]},"references-count":51,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["S0026049507003289"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2007.09.008","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2008,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differential effect of fenofibrate and atorvastatin on in vivo kinetics of apolipoproteins B-100 and B-48 in subjects with type 2 diabetes mellitus with marked hypertriglyceridemia","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2007.09.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}